申请人:WALLACE L. JOHN
公开号:US20060003972A1
公开(公告)日:2006-01-05
The present invention provides L-arginine salts of 4- or 5-aminosalicylic acid, and a pharmaceutical composition containing these L-arginine salts of 4- or 5-aminosalicylic acid as active ingredients, useful for the treatment of an inflammatory condition of the GI tract such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS).
本发明提供了4-或5-氨基水杨酸的L-精氨酸盐,并提供了一种药物组合物,其中包含这些L-精氨酸盐作为活性成分,用于治疗胃肠道的炎症性疾病,例如炎症性肠病(IBD)和肠易激综合征(IBS)。